Join Wilson Sonsini Senior Counsel Dan Orr on January 20, 2026, as he and fellow panelists participate in an HSBC Innovation and Healthcare Innovation Catalysts briefing on the current status of FDA operations. As a new year begins, this webinar is intended to assist leaders on understanding what has changed at the FDA, what has not, and what insiders are seeing from the current environment. Moderated by Deborah Autor, former FDA Deputy Commission for Global Operations, the speakers will discuss practical and real-time insights on three critical areas: drug review, medical devices, and legal and regulatory risk. Dan will address policy making, legal risk, and what companies should be factoring into compliance and regulatory planning.
To register for the free webinar, please visit the registration site.
Hannah Hebertson
hhebertson@wsgr.com
Dan Orr is senior counsel at Wilson Sonsini Goodrich & Rosati, where he brings an insider’s perspective to helping clients prevent and solve problems with the U.S. Food & Drug Administration. Dan, a former FDA regulatory counsel, has more than 20 years of experience concerning regulation of drugs, biologics, and medical devices.